ArticleCancer drug resistance (Alhambra, Calif.)2021

Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment.

John K Cowell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.